Skip to content
  • de Bock M, McAuley SA, Abraham M, Smith G, Nicholas J, Geelhoed EA, Davis EA, O’Neal DN, Jones TW on behalf of the Australian Closed-Loop Research Group. Safety and efficacy of hybrid closed loop insulin delivery: Protocol for a 6 month multi-centre parallel design randomised controlled trial to evaluate outpatient hybrid closed loop therapy compared to standard therapy in people with type 1 diabetes aged 12 to <25 years of age. BMJ Open. 2018 In press.
  • McAuley SA, de Bock M, Sundararajan V, Bach LA, Burt MG, Cohen ND, Coleman PG, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, MacIsaac RJ, McCallum RW, Speight J, Stranks SN, Ward GM, Jones TW, O’Neal DN, for the Australian JDRF Closed-Loop Research Group. Effectiveness of 6 months hybrid closed-loop insulin delivery on glucose control, psychosocial well-being, sleep and cognition in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018;8(6).
  • de Bock M, Rossborough J, Siafarikas A, Evans M, Clapin H, Smith G, Jones TW, Davis EA. Insulin Pump Therapy in Adolescents With Very Poor Glycemic Control During a 12-Month Cohort Trial. Journal of Diabetes Science and Technology. 2018 doi: 10.1177/1932296818769338. [Epub ahead of print]
  • Leow Z, Guelfi K, Davis EA, Jones TW, Fournier P. (2018) The Glycaemic benefits of a very low carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabetic Medicine May 8. doi: 10.1111/dme.13663. [Epub ahead of print]
  • Abraham MB, Heels K, Nicholas JA, Cole C, Gerbert R, Klimek J, Jopling T, Ambler G, Cameron F, Davis EA, Jones TW, on behalf of the PLGM Study Group Unexpected Management Behaviors in Adolescents with Type 1 Diabetes Using Sensor-Augmented Pump Therapy. Journal of Diabetes Science and Technology. 2018;12(3):592-598.
  • Benitez-Aguirre PZ, Wong TY, Craig ME, Davis EA, Cotterill A, Couper JJ, Cameron FJ, Mahmud FH, Jones TW, Hodgson LAB, Dalton RN, Dunger DB, Donaghue KC. The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes. Diabetologia. 2018;61(4):968-976.
  • Haynes A, Bulsara M, Jones TW, Davis EA. Incidence of Childhood Onset type 1 diabetes in Western Australia from 1985 to 2016: evidence for a plateau. (2018) Paediatric Diabetes. 2018;19(4):690-692.
  • Abraham MB, Nicholas JA, Smith G, Fairchild JM,  King BR, Ambler GR, FJ C, Davis EA, Jones TW, on behalf of the PLGM Study Group. (2018) Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-Term Randomized Controlled Trial in Adolescents With Type 1 Diabetes. Diabetes Care. 2018;41(2):303-310.
  • de Bock M, Lobley K, Anderson D, Davis EA, Donaghue K, Pappas M, Siafarikas A, Cho YH, Jones TW, Smart C. Endocrine and metabolic consequences due to restrictive carbohydrate diets in children with type 1 diabetes: An illustrative case series. Paediatric Diabetes. 2018;19(1):129-137.
  • Joshi KK, Haynes A, Smith G, Jones TW, Davis EA. Comparable Glycemic Outcomes for Paediatric Type 1 Diabetes Patients in metropolitan and non-metropolitan regions of Western Australia: A population-based study. Pediatric Diabetes. 2018;19(3):486-492.
  • Abraham MB, Nicholas JA, Crone M, Ly TT, Davis EA, Jones TW. The Importance of the Hawthorne Effect on Psychological Outcomes Unveiled in a Randomized Controlled Trial of Diabetes Technology. Journal of Diabetes Science and Technology. 2018;12(3)735-736.
  • Jones TW On behalf of the ISPAD Hypoglycemia Guidelines Writing Group. Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes. Pediatric Diabetes. 2018;19(3):354-355.

 

  • Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, Kowalski A, Rabasa-Lhoret R, McCrimmon RJ, Hume C, Annan F, Fournier PA, Graham C, Bode B, Galassetti P, Jones TW, Millan IS, Heise T, Peters AL, Petz A, Laffel LM. Exercise management in type 1 diabetes: a consensus statement. The Lancet Diabetes & Endocrinology. 2017;5(5):377-90.

  • Paramalingam N, Fournier PA, Davey RJ, Roby HC, Smith GJ, Shetty VB, Guelfi KJ, Davis EA, Jones TW. A 10-second sprint does not blunt hormonal counter-regulation to subsequent hypoglycaemia. Diabetic Medicine: A Journal of the British Diabetic Association. 2017;34(10):1440-6.

  • Nicholas JA, Gill FJ, Elliott L, Abraham MB, Cross D, Jones TW, Davis EA. Sensor-augmented pump therapy in the management of type 1 diabetes: lived experiences of children, adolescents and parents. Australian Diabetes Educator. 2017;20(2).

  • Marcovecchio ML, Chiesa ST, Bond S, Daneman D, Dawson S, Donaghue KC, Jones TW, Mahmud FH, Marshall SM, Neil HAW, Dalton RN, Deanfield J, Dunger DB, for the AdDIT Study Group. ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes. The New England Journal of Medicine. 2017;377(18):1733-45.

  • Joshi KK, Haynes A, Smith G, Jones TW, Davis EA. Comparable glycemic outcomes for pediatric type 1 diabetes patients in metropolitan and non-metropolitan regions of Western Australia: A population-based study. Pediatric Diabetes. 2017;epub ahead of print.

  • Jones TW On behalf of the ISPAD Hypoglycemia Guidelines Writing Group. Defining relevant hypoglycemia measures in children and adolescents with type 1 diabetes. Pediatric Diabetes. 2017;epub ahead of print.

  • International Hypoglycaemia Study Group. Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. Diabetologia. 2017;60(1):3-6.

  • International Hypoglycaemia Study Group. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care. 2017;40(1):155-7.

  • Graf A, Ward GM, Vogrin S, Sundararajan V, Sharifi A, De Bock M, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Jenkins AJ, Kumareswaran KV, Kurtz N, Kyoong A, MacIsaac AJ, Roy A, Jones TW, O’Neal DN. Overnight Counter-regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes during Closed-Loop Insulin Delivery versus Sensor-Augmented Pump with Low-Glucose Suspend. Diabetes Technology and Therapeutics. 2017;19(7):438-9.

  • Gibson LY, Allen KL, Davis EA, Blair E, Zubrick SR, Byrne SM. The psychosocial burden of childhood overweight and obesity: evidence for persisting difficulties in boys and girls. European Journal of Pediatrics. 2017;176(7):925-33.

  • de Bock M, Lobley K, Anderson D, Davis EA, Donaghue K, Pappas M, Siafarikas A, Cho YH, Jones TW, Smart C. Endocrine and metabolic consequences due to restrictive carbohydrate diets in children with type 1 diabetes: An illustrative case series. Pediatric Diabetes. 2017;epub ahead of print.

  • Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, Hans DeVries J, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle III FJ, Heller S, Hovorka R, Jia W, Jones TW, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, M. P. International Consensus on Use of Continuous Glucose Monitoring. Diabetes care. 2017;40(12):1631-40.

  • Craig ME, Prinz N, Boyle C, Campbell FM, Jones TW, Hofer SE, Simmons JH, Holman N, Tham E, Fröhlich-Reiterer E, DuBose S, Thornton H, King B, Maahs DM, Holl RW and Warner JT on behalf of the Australasian Diabetes Data Network (ADDN), the T1D Exchange the National Paediatric Diabetes Audit (NPDA), and the Royal College of Paediatrics and Child Health and the Prospective Diabetes Follow-up Registry (DPV) initiative. Prevalence of Celiac Disease in 52,721 Youth with Type 1 Diabetes: international comparison across three continents. Diabetes care. 2017;40(8):1034-40.

  • Cooper MN, de Bock MI, Carter KW, de Klerk NH, Jones TW, Davis EA. Incidence of and risk factors for hospitalisations due to vascular complications: A population-based type 1 diabetes cohort (n=1316) followed into early adulthood. Journal of Diabetes and its Complications. 2017;31(5):843-9.

  • Abraham MB, Larkins N, Choong CS, Shetty VB. Transient pseudohypoaldosteronism in infancy secondary to urinary tract infection. Journal of Paediatrics and Child Health. 2017;53(5):458-63.

  • Abraham MB, Davey RJ, Cooper MN, Paramalingam N, O'Grady MJ, Ly TT, Jones TW, Fournier PA, Davis EA. Reproducibility of the plasma glucose response to moderate-intensity exercise in adolescents with Type 1 diabetes. Diabetic medicine : A Journal of the British Diabetic Association. 2017;34(9):1291-5.

  • Abraham M, Li D, Tang D, O’Connell S, McKenzie F, Lim E, Hakonarson H, Levine M, Choong C. Short stature and hypoparathyroidism in a child with Kenny-Caffey syndrome type 2 due to a novel mutation in FAM111A gene. International Journal of Pediatric Endocrinology. 2017;2017(1):1.
  • Shetty VB, Fournier PA, Davey RJ, Retterath AJ, Paramalingam N, Roby HC, et al. Effect of exercise intensity on glucose requirements to maintain euglycaemia during exercise in type 1 diabetes. J Clin Endocrinol Metab. 2016:jc20154026.
  • Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, et al. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016.
  • Phelan H, Clapin, H,  Bruns Jr. L, Cameron, FJ, Cotterill, AM, Couper, JJ,  Davis, EA,  Donaghue, KC, Jefferies, C, King, B, Sinnott, RO, Tham, E, Wales, JK, Jones, TW, Craig, ME. On Behalf of the ADDN Study group. . The Australasian Diabetes Data Network (ADDN): First National Audit Data on Youth with Type 1 Diabetes. The Medical journal of Australia. 2016.
  • Naylor LH, Davis EA, Kalic RJ, Paramalingam N, Abraham MB, Jones TW, et al. Exercise training improves vascular function in adolescents with type 2 diabetes. Physiological reports. 2016;4(4).
  • Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, et al. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report. Diabetes care. 2016;39(7):1175-9.
  • Haynes A, Kalic R, Cooper M, Hewitt JK, Davis EA. Increasing incidence of type 2 diabetes in Indigenous and non-Indigenous children in Western Australia, 1990-2012. Med J Aust. 2016;204(8):303.
  • Haynes A, Hermann JM, Miller KM, Hofer SE, Jones TW, Beck RW, et al. Severe hypoglycemia rates are not associated with HbA1c: a cross‐sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatric Diabetes. 2016.
  • de Bock MD, J, Roy, A,  Davey, R, Soon, R,  Berthold, C , Retterath, A,  Grosman, B, Kurtz, N, Davis, E, Jones, T. . Exploration of the performance of a hybrid closed loop insulin delivery algorithm that includes insulin delivery limits designed to protect against hypoglycemia. . Journal of Diabetes Science and Technology. 2016.
  • de Bock M, Cooper M, Retterath A, Nicholas J, Ly T, Jones T, et al. Continuous Glucose Monitoring Adherence Lessons From a Clinical Trial to Predict Outpatient Behavior. Journal of diabetes science and technology. 2016:1932296816633484.
  • Cooper MN, McNamara KAR, de Klerk NH, Davis EA, Jones TW. School performance in children with type 1 diabetes: a contemporary population-based study. Pediatric Diabetes. 2016:n/a-n/a.
  • Cooper MN, Lin A, Alvares GA, Klerk NHd, Jones TW, Davis EA. Psychiatric disorders during early adulthood in those with childhood onset type 1 diabetes: Rates and clinical risk factors from population‐based follow‐up. Pediatric Diabetes. 2016.
  • Clapin H, Phelan H, Bruns L, Jr., Sinnott R, Colman P, Craig M, et al. Australasian Diabetes Data Network: Building a Collaborative Resource. J Diabetes Sci Technol. 2016.
  • Clapin H, Hop L, Ritchie E, Jayabalan R, Evans M, Browne-Cooper K, et al. Home-based vs inpatient education for children newly diagnosed with type 1 diabetes. Pediatric diabetes. 2016.
  • Abraham MB, Shetty VB, McKenzie F, Curran J. X-linked Congenital Adrenal Hypoplasia with a Novel NR0B1/DAX Gene Mutation. Indian pediatrics. 2016;53(6):529-31.
  • Abraham MB, Nicholas JA, Ly TT, Roby HC, Paramalingam N, Fairchild J, et al. Safety and efficacy of the predictive low glucose management system in the prevention of hypoglycaemia: protocol for randomised controlled home trial to evaluate the Suspend before low function. BMJ open. 2016;6(4):e011589.
  • Abraham MB, Gallego PH, Brownlee WM, Smith GJ, Davis EA, Jones TW. Reduced prevalence of impaired awareness of hypoglycemia in a population-based clinic sample of youth with type 1 diabetes. Pediatric diabetes. 2016.
  • Abraham MB, de Bock M, Paramalingam N, O'Grady MJ, Ly TT, George C, et al. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System. Diabetes Technol Ther. 2016.
  • Abraham MB, Davey R, O'Grady MJ, Ly TT, Paramalingam N, Fournier PA, et al. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes. Diabetes Technol Ther. 2016.
  • Straker LM, Hall GL, Mountain J, Howie EK, White E, McArdle N, et al. Rationale, design and methods for the 22 year follow-up of the Western Australian Pregnancy Cohort (Raine) Study. BMC public health. 2015;15:663.
  • Justice TD, Hammer GL, Davey RJ, Paramalingam N, Guelfi KJ, Lewis L, et al. Effect of antecedent moderate-intensity exercise on the glycemia-increasing effect of a 30-sec maximal sprint: a sex comparison. Physiological reports. 2015;3(5).
  • Huang RC, Prescott SL, Godfrey KM, Davis EA. Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. J Nutr Sci. 2015;4:e12.
  • Huang RC, Garratt ES, Pan H, Wu Y, Davis EA, Barton SJ, et al. Genome-wide methylation analysis identifies differentially methylated CpG loci associated with severe obesity in childhood. Epigenetics. 2015;10(11):995-1005.
  • Haynes A, Bulsara MK, Bower C, Jones TW, Davis EA. Regular peaks and troughs in the Australian incidence of childhood type 1 diabetes mellitus (2000-2011). Diabetologia. 2015;58(11):2513-6.
  • Group IHS. Minimizing Hypoglycemia in Diabetes. Diabetes care. 2015;38(8):1583-91.
  • de Bock MI, Roy A, Cooper MN, Dart JA, Berthold CL, Retterath AJ, et al. Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery. Diabetes care. 2015;38(11):e186-7.
  • Cho YH, Craig ME, Davis EA, Cotterill AM, Couper JJ, Cameron FJ, et al. Cardiac Autonomic Dysfunction Is Associated With High-Risk Albumin-to-Creatinine Ratio in Young Adolescents With Type 1 Diabetes in AdDIT (Adolescent Type 1 Diabetes Cardio-Renal Interventional Trial). Diabetes care. 2015.
  • Anderson D, Cordell HJ, Fakiola M, Francis RW, Syn G, Scaman ES, et al. First genome-wide association study in an Australian aboriginal population provides insights into genetic risk factors for body mass index and type 2 diabetes. PloS one. 2015;10(3):e0119333.
  • Abraham MB, Shetty VB, Price G, Smith N, Bock M, Siafarikas A, et al. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia. J Pediatr Endocrinol Metab. 2015;28(11-12):1391-8.
  • Abraham MB, Charles A, Gera P, Srinivasjois R. Surgically managed perinatal testicular torsion: a single centre experience. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2015:1-4.
  • Roberts G, Jones TW, Davis EA, Ly TT, Anderson M. Building tasks from verbal instructions: an EEG study on practice trial exposure and task structure complexity during novel sequences of behavior. Cognitive, affective & behavioral neuroscience. 2014;14(4):1356-74. 
  • Rath SR, Bartley A, Charles A, Powers N, Baynam G, Jones T, et al. Multinodular Goiter in children: an important pointer to a germline DICER1 mutation. J Clin Endocrinol Metab. 2014;99(6):1947-8.
  • Naylor LH, Yusof NM, Paramalingam N, Jones TW, Davis EA, Green DJ. Acute hyperglycaemia does not alter nitric oxide-mediated microvascular function in the skin of adolescents with type 1 diabetes. European journal of applied physiology. 2014;114(2):435-41.
  • McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, et al. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic medicine : a journal of the British Diabetic Association. 2014.
  • Marcovecchio ML, Woodside J, Jones TW, Daneman D, Neil A, Prevost T, et al. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): Urinary Screening and Baseline Biochemical and Cardiovascular Assessments. Diabetes care. 2014;37(3):805-13.
  • Maftei O, Pena AS, Sullivan T, Jones TW, Donaghue KC, Cameron FJ, et al. Early Atherosclerosis Relates to Urinary Albumin Excretion and Cardiovascular Risk Factors in Adolescents With Type 1 Diabetes: Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT). Diabetes care. 2014;37(11):3069-75.
  • Ly TT, Maahs DM, Rewers A, Dunger D, Oduwole A, Jones TW. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric diabetes. 2014;15 Suppl 20:180-92.
  • Ly TT, Brnabic AJ, Eggleston A, Kolivos A, McBride ME, Schrover R, et al. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2014;17(5):561-9.
  • Huang RC, Davis EA. Effect of Postnatal Growth in the Large-for-Gestational-Age Infants. In: Griffin IJ, editor. Perinatal Growth and Nutrition: CRC Press; 2014. p. 119-48.
  • Haynes A, Cooper MN, Bower C, Jones TW, Davis EA. Maternal smoking during pregnancy and the risk of childhood type 1 diabetes in Western Australia. Diabetologia. 2014;57(3):469-72.
  • Davey R, Paramalingam N, Retterath A, Lim EM, Davis EA, Jones TW, et al. Antecedent hypoglycaemia does not diminish the glycaemia-increasing effect and glucoregulatory responses of a 10 s sprint in people with type 1 diabetes. Diabetologia. 2014;57(6):1111-8.
  • Cooper MN, de Klerk NH, Jones TW, Davis EA. Clinical and demographic risk factors associated with mortality during early adulthood in a population-based cohort of childhood-onset Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2014;31(12):1550-8.
  • Ball SJ, Haynes A, Jacoby P, Pereira G, Miller LJ, Bower C, et al. Spatial and temporal variation in type 1 diabetes incidence in Western Australia from 1991 to 2010: increased risk at higher latitudes and over time. Health & place. 2014;28:194-204.
  • Allen KL, Gibson LY, McLean NJ, Davis EA, Byrne SM. Maternal and family factors and child eating pathology: risk and protective relationships. Journal of eating disorders. 2014;2:11.
  • Wake M, Campbell MW, Turner M, Price A, Sabin MA, Davis EA, et al. How training affects Australian Paediatricians' management of obesity. Archive of Diseases in Childhood. 2013;98.
  • Smart CE, Evans M, O'Connell SM, McElduff P, Lopez PE, Jones TW, et al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes care. 2013;36(12):3897-902.
  • Penno MAS, Couper JJ, Craig ME, Colman PG, Rawlinson WD, Cotterill AM, et al. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC pediatrics. 2013;13(1):1-15.
  • O'Grady MJ, Delaney J, Jones TW, Davis EA. Standardised mortality is increased three-fold in a population-based sample of children and adolescents with type 1 diabetes. Pediatric Diabetes. 2013;14(1):13-7.
  • Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Jama. 2013;310(12):1240-7.
  • Jones TW. Insulin pumps that suspend when glucose is low: pumps of the future. Diabetes Management Journal. 2013;42.
  • Johnson SR, Cooper MN, Jones TW, Davis EA. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56(11):2392-400.
  • Johnson SR, Cooper MN, Davis EA, Jones TW. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents. Diabetic medicine : a journal of the British Diabetic Association. 2013;30(9):1126-31.
  • Ham S, Meachem SJ, Choong CS, Charles AK, Baynam GS, Jones TW, et al. Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz-Jeghers syndrome. The Journal of clinical endocrinology and metabolism. 2013;98(12):E1979-87.
  • Davey RJ, Howe W, Paramalingam N, Ferreira LD, Davis EA, Fournier PA, et al. The effect of midday moderate-intensity exercise on postexercise hypoglycemia risk in individuals with type 1 diabetes. The Journal of clinical endocrinology and metabolism. 2013;98(7):2908-14.
  • Davey RJ, Bussau VA, Paramalingam N, Ferreira LD, Lim EM, Davis EA, et al. A 10-s sprint performed after moderate-intensity exercise neither increases nor decreases the glucose requirement to prevent late-onset hypoglycemia in individuals with type 1 diabetes. Diabetes care. 2013;36(12):4163-5.
  • Cooper MN, O'Connell SM, Davis EA, Jones TW. A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes. Diabetologia. 2013;56(10):2164-70.
  • Cameron F, Cotterill A, Couper J, Craig M, Davis EA, Donaghue K, et al. Short report: Care for children and adolescents with diabetes in Australia and New Zealand: Have we achieved the defined goals? Journal of Paediatrics and Child Health. 2013;49(4):E258-E62.
  • Bell L, Hung J, Knuiman M, Divitini M, Beilby J, Hunter M, et al. Body mass index and waist circumference: relationship to cardiometabolic risk factors in children--Busselton Health Study 2005-2007. J Paediatr Child Health. 2013;49(11):955-62.
  • Suriano K, Curran J, Byrne S, Davis EA. Sedentary behaviour increases metabolic risk in young children (in press). International Journal of Pediatric Obesity. 2012.
  • Siafarikas A, Johnston RJ, Bulsara MK, O'Leary P, Jones TW, Davis EA. Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes care. 2012;35(8):1757-62.
  • Shetty VB, Bower C, Jones TW, Lewis BD, Davis EA. Ethnic and gender differences in rates of congenital adrenal hyperplasia in Western Australia over a 21 year period. Journal of Paediatrics and Child Health. 2012;48(11):1029-32.
  • Ong GSY, Somerville CP, Jones TW, Walsh JP. Anaphylaxis triggered by benzyl benzoate in a preparation of depot testosterone undecanoate. Case Reports in Medicine. 2012;2012.
  • O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes care. 2012;35(11):2182-7.
  • O'Grady MJ, McGrath N, Quinn FM, Capra ML, McDermott MB, Murphy NP. Spermatogenesis in a prepubertal boy. J Pediatr. 2012;161(2):369-.e1.
  • Munns CF, Simm PJ, Rodda CP, Garnett SP, Zacharin MR, Ward LM, et al. Incidence of vitamin D deficiency rickets among Australian children: an Australian Paediatric Surveillance Unit study. Med J Aust. 2012;196(7):466-8.
  • Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes care. 2012;35(7):1462-5.
  • Ly TT, Jones TW, Griffiths A, Dart J, Davis EA, Stick S, et al. Hypoglycemia does not change the threshold for arousal from sleep in adolescents with type 1 diabetes. Diabetes technology & therapeutics. 2012;14(2):101-4.
  • Ly TT, Jones TW. Managing hypoglycemia in children: what the clinician needs to know before advising parents. Diabetes Management. 2012;2(6):503-12.
  • Johnson SR, Nolan RC, Grant MT, Price GJ, Siafarikas A, Bint L, et al. Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty. J Paediatr Child Health. 2012;48(3):E136-9.
  • Iscoe KE, Davey RJ, Fournier PA. Do different glucose levels at calibration influence accuracy of continuous glucose monitoring readings in vitro? J Diabetes Sci Technol. 2012;6(2):477-8.
  • Haynes A, Bulsara MK, Bower C, Jones TW, Davis EA. Cyclical variation in the incidence of childhood type 1 diabetes in Western Australia (1985-2010). Diabetes care. 2012;35(11):2300-2.
  • Fahey AJ, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA. The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. The Journal of clinical endocrinology and metabolism. 2012;97(11):4193-200.
  • Davey RJ, Stevens K, Jones TW, Fournier PA. The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. Primary care diabetes. 2012;6(1):35-9.
  • Couper J, Jones TW. Diabetes. In: South M, Isaacs D, editors. Practical Paediatrics 7ed: Churchill Livingston Elsevier; 2012. p. 687.
  • Bell L, Davis E, Knuiman M, Divitini M, Beilby J, Hunter M, et al. Lipids in Australian children: cause for concern? 2005-2007 Busselton Health Study. J Paediatr Child Health. 2012;48(10):E172-7.
  • Williams BK, Guelfi KJ, Jones TW, Davis EA. Lower cardiorespiratory fitness in children with Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2011;28(8):1005-7.
  • Siafarikas A, Piazena H, Feister U, Bulsara MK, Meffert H, Hesse V. Randomised controlled trial analysing supplementation with 250 versus 500 units of vitamin D3, sun exposure and surrounding factors in breastfed infants. Arch Dis Child. 2011;96(1):91-5.
  • O'Connell SM, Johnson SR, Lewis BD, Staltari L, Peverall J, Ly T, et al. Structural chromosome disruption of the NR3C2 gene causing pseudohypoaldosteronism type 1 presenting in infancy. Journal of pediatric endocrinology & metabolism : JPEM. 2011;24(7-8):555-9.
  • O'Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes care. 2011;34(11):2379-80.
  • NHMRC - Expert Advisory Group. National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes for Children, Adolescents and Adults.  National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes for Children, Adolescents and Adults. Australia: APEG; 2011.
  • Nguyen LB, Ling SS, Jones TW, Nguyen HT. Identification of hypoglycemic states for patients with T1DM using various parameters derived from EEG signals. Conference proceedings :  Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2011;2011:2760-3.
  • Naylor LH, Green DJ, Jones TW, Kalic RJ, Suriano KL, Shah M, et al. Endothelial function and carotid intima-medial thickness in adolescents with type 2 diabetes mellitus. The Journal of pediatrics. 2011;159(6):971-4.
  • Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes care. 2011;34(1):50-2.
  • Ly TT, Anderson M, McNamara KA, Davis EA, Jones TW. Neurocognitive outcomes in young adults with early-onset type 1 diabetes: a prospective follow-up study. Diabetes care. 2011;34(10):2192-7.
  • Iscoe KE, Davey RJ, Fournier PA. Increasing the low-glucose alarm of a continuous glucose monitoring system prevents exercise-induced hypoglycemia without triggering any false alarms. Diabetes care. 2011;34(6):e109.
  • Bell LM, Curran JA, Byrne S, Roby H, Suriano K, Jones TW, et al. High incidence of obesity co-morbidities in young children: a cross-sectional study. Journal of Paediatrics and Child Health. 2011;47(12):911-7.
  • Suriano K, Curran J, Byrne SM, Jones TW, Davis EA. Fatness, fitness, and increased cardiovascular risk in young children. The Journal of pediatrics. 2010;157(4):552-8.
  • Skladnev VN, Tarnavskii S, McGregor T, Ghevondian N, Gourlay S, Jones TW. Hypoglycemia alarm enhancement using data fusion. Journal of diabetes science and technology. 2010;4(1):34-40.
  • Skladnev VN, Ghevondian N, Tarnavskii S, Paramalingam N, Jones TW. Clinical evaluation of a noninvasive alarm system for nocturnal hypoglycemia. Journal of diabetes science and technology. 2010;4(1):67-74.
  • Siafarikas A, O'Connell S. Type 1 diabetes in children - emergency management. Australian family physician. 2010;39(5):290-3.
  • O'Connell S, Siafarikas A. Addison disease - diagnosis and initial management. Australian family physician. 2010;39(11):834-7.
  • Nguyen HT, Jones TW. Detection of nocturnal hypoglycemic episodes using EEG signals. Conference proceedings :  Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference. 2010;2010:4930-3.
  • Maple-Brown LJ, Sinha AK, Davis EA. Type 2 diabetes in indigenous Australian children and adolescents. J Paediatr Child Health. 2010;46(9):487-90.
  • Howe W, Davis E, Valentine J. Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions. Developmental neurorehabilitation. 2010;13(1):31-6.
  • Davey RJ, Low C, Jones TW, Fournier PA. Contribution of an intrinsic lag of continuous glucose monitoring systems to differences in measured and actual glucose concentrations changing at variable rates in vitro. Journal of diabetes science and technology. 2010;4(6):1393-9.
  • Davey RJ, Jones TW, Fournier PA. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. Journal of diabetes science and technology. 2010;4(6):1457-64.
  • Cardwell CR, Stene LC, Joner G, Davis EA, Cinek O, Rosenbauer J, et al. Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data. Diabetologia. 2010;53(4):641-51.
  • O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia. 2009;52(7):1250-7.
  • Marcovecchio LM, Dunger DB, Dalton RN, Daneman D, Deanfield JE, Gray A, et al. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC pediatrics. 2009;9:79.
  • Ly TT, Jones TW. Hypoglycemia in Children and Adolescents. Diabetic Hypoglycemia. 2009;2(2):8.
  • Ly TT, Gallego PH, Davis EA, Jones TW. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes. Diabetes care. 2009;32(10):1802-6.
  • Jones TW. Recurrent severe hypoglycemia in an adolescent with type 1 diabetes. Diabetic Hypoglycaemia. 2009;2(2):17-8.
  • Ghosh S, Nagarajan L, Bulsara M, Davis EA, Carne CL, Jones TW. Effects of hypoglycaemia on the brain in children with Type 1 Diabetes Mellitus: Changes in EEG and Quantitative EEG. Journal of Clinical Neuroscience. 2009;16(11):1545.
  • Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric diabetes. 2009;10 Suppl 12:134-45.
  • Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). Adolescent type 1 Diabetes Cardio-renal Intervention Trial research Group. BMC pediatrics. 2009;9(79).
  • Watts K, Bell LM, Byrne SM, Jones TW, Davis EA. Waist circumference predicts cardiovascular risk in young Australian children. Journal of Paediatrics and Child Health. 2008;44(12):709-15.
  • Naylor LH, Watts K, Sharpe JA, Jones TW, Davis EA, Thompson A, et al. Resistance training and diastolic myocardial tissue velocities in obese children. Medicine and science in sports and exercise. 2008;40(12):2027-32.
  • Lampard AM, Byrne SM, Zubrick SR, Davis EA. Parents' concern about their children's weight. International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity. 2008;3(2):84-92.
  • Ho MS, Weller NJ, Ives FJ, Carne CL, Murray K, Vanden Driesen RI, et al. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus. The Journal of pediatrics. 2008;153(3):385-90.
  • Gibson LY, Byrne SM, Blair E, Davis EA, Jacoby P, Zubrick SR. Clustering of psychosocial symptoms in overweight children. The Australian and New Zealand journal of psychiatry. 2008;42(2):118-25.
  • Gallego PH, Shephard N, Bulsara MK, van Bockxmeer FM, Powell BL, Beilby JP, et al. Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. Journal of diabetes and its complications. 2008;22(3):191-8.
  • Clarke W, Jones T, Rewers A, Dunger D, Klingensmith GJ. Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes. 2008;9(2):165.
  • Allen KL, Byrne SM, McLean NJ, Davis EA. Overconcern with weight and shape is not the same as body dissatisfaction: evidence from a prospective study of pre-adolescent boys and girls. Body image. 2008;5(3):261-70.
  • Allen KL, Byrne SM, La Puma M, McLean N, Davis EA. The onset and course of binge eating in 8- to 13-year-old healthy weight, overweight and obese children. Eating behaviors. 2008;9(4):438-46.
  • McMahon SK, Ferreira LD, Ratnam N, Davey RJ, Youngs LM, Davis EA, et al. Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. The Journal of clinical endocrinology and metabolism. 2007;92(3):963-8.
  • Haynes A, Bower C, Bulsara MK, Finn J, Jones TW, Davis EA. Perinatal risk factors for childhood Type 1 diabetes in Western Australia--a population-based study (1980-2002). Diabetic medicine : a journal of the British Diabetic Association. 2007;24(5):564-70.
  • Guelfi KJ, Ratnam N, Smythe GA, Jones TW, Fournier PA. Effect of intermittent high-intensity compared with continuous moderate exercise on glucose production and utilization in individuals with type 1 diabetes. American journal of physiology Endocrinology and metabolism. 2007;292(3):E865-70.
  • Guelfi KJ, Jones TW, Fournier PA. New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines. Sports Medicine. 2007;37(11):937-46.
  • Gracey M, Burke V, Martin DD, Johnston RJ, Jones TW, Davis EA. Assessment of risks of" lifestyle" diseases including cardiovascular disease and type 2 diabetes by anthropometry in remote Australian Aborigines. Asia Pacific journal of clinical nutrition. 2007;16(4):688-97.
  • Gibson LY, Byrne SM, Davis EA, Blair E, Jacoby P, Zubrick SR. The role of family and maternal factors in childhood obesity. Med J Aust. 2007;186(11):591-5.
  • Dunger DB, Schwarze CP, Cooper JD, Widmer B, Neil HA, Shield J, et al. Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabetic medicine : a journal of the British Diabetic Association. 2007;24(2):131-6.
  • Craig ME, Jones TW, Silink M, Ping YJ. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region. Journal of diabetes and its complications. 2007;21(5):280-7.
  • Bussau VA, Ferreira LD, Jones TW, Fournier PA. A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes. Diabetologia. 2007;50(9):1815-8.
  • Bulsara MK, Holman CD, van Bockxmeer FM, Davis EA, Gallego PH, Beilby JP, et al. The relationship between ACE genotype and risk of severe hypoglycaemia in a large population-based cohort of children and adolescents with type 1 diabetes. Diabetologia. 2007;50(5):965-71.
  • Bell LM, Watts K, Siafarikas A, Thompson A, Ratnam N, Bulsara M, et al. Exercise alone reduces insulin resistance in obese children independently of changes in body composition. The Journal of clinical endocrinology and metabolism. 2007;92(11):4230-5.
  • Bell LM, Byrne S, Thompson A, Ratnam N, Blair E, Bulsara M, et al. Increasing body mass index z-score is continuously associated with complications of overweight in children, even in the healthy weight range. The Journal of clinical endocrinology and metabolism. 2007;92(2):517-22.
  • Watts K, Naylor LH, Davis EA, Jones TW, Beeson B, Bettenay F, et al. Do skinfolds accurately assess changes in body fat in obese children and adolescents? Medicine and science in sports and exercise. 2006;38(3):439-44.
  • Siafarikas A, Cherian S, Vicca N, Jones TW, Burgner D. Vitamin D Deficiency in Migrants. In: Stoltz VD, editor. New Topics in Vitamin D Research. New York: Nova Publishers; 2006. p. 199-221.
  • Sharpe JA, Naylor LH, Jones TW, Davis EA, O'Driscoll G, Ramsay JM, et al. Impact of obesity on diastolic function in subjects < or = 16 years of age. The American journal of cardiology. 2006;98(5):691-3.
  • Martin DD, Davis EA, Jones TW. Acute effects of hyperglycaemia in children with type 1 diabetes mellitus: the patient's perspective. Journal of pediatric endocrinology & metabolism : JPEM. 2006;19(7):927-36.
  • Haynes A, Bulsara MK, Bower C, Codde JP, Jones TW, Davis EA. Independent effects of socioeconomic status and place of residence on the incidence of childhood type 1 diabetes in Western Australia. Pediatric Diabetes. 2006;7(2):94-100.
  • Gallego PH, Bulsara MK, Frazer F, Lafferty AR, Davis EA, Jones TW. Prevalence and risk factors for microalbuminuria in a population-based sample of children and adolescents with T1DM in Western Australia. Pediatric Diabetes. 2006;7(3):165-72.
  • Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Current medical research and opinion. 2006;22(5):1013-20.
  • Davis EA, Haynes A. Why is Type 1 diabetes becoming more common in children? Diabetes Management. 2006.
  • Davey RJ, Ferreira LD, Jones TW, Fournier PA. Effect of exercise-mediated acidosis on determination of glycemia using CGMS. Diabetes technology & therapeutics. 2006;8(4):516-8.
  • Bussau VA, Ferreira LD, Jones TW, Fournier PA. The 10-s maximal sprint: a novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes. Diabetes care. 2006;29(3):601-6.
  • Anderson AW, Heptulla RA, Driesen N, Flanagan D, Goldberg PA, Jones TW, et al. Effects of hypoglycemia on human brain activation measured with fMRI. Magnetic resonance imaging. 2006;24(6):693-7.
  • Allen KL, Byrne SM, Blair EM, Davis EA. Why do some overweight children experience psychological problems? The role of weight and shape concern. International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity. 2006;1(4):239-47.
  • Windsor L, Puschendorf M, Allcock R, Scott A, Sayer D, Kucharzak R, et al. Does a central MHC gene in linkage disequilibrium with HLA-DRB1*0401 affect susceptibility to type 1 diabetes? Genes & Immunity. 2005;6(4):298-304.
  • Watts K, Jones TW, Davis EA, Green D. Exercise training in obese children and adolescents: current concepts. Sports Medicine. 2005;35(5):375-92.
  • Strudwick SK, Carne C, Gardiner J, Foster JK, Davis EA, Jones TW. Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia. The Journal of pediatrics. 2005;147(5):680-5.
  • Outschoorn IM, Rose NR, Lynne Burek C, Jones TW, Mackay IR, Rowley MJ. Heritability of levels of autoantibodies using the method of plotting regression of offspring on midparent (ROMP). Autoimmunity. 2005;38(4):325-6.
  • McMahon SK, Airey FL, Marangou DA, McElwee KJ, Carne CL, Clarey AJ, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabetic medicine : a journal of the British Diabetic Association. 2005;22(1):92-6.
  • Martin DD, Shephard MD, Freeman H, Bulsara MK, Jones TW, Davis EA, et al. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community. The Medical journal of Australia. 2005;182(10):524-7.
  • Guelfi KJ, Jones TW, Fournier PA. Intermittent high-intensity exercise does not increase the risk of early postexercise hypoglycemia in individuals with type 1 diabetes. Diabetes care. 2005;28(2):416-8.
  • Guelfi KJ, Jones TW, Fournier PA. The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes care. 2005;28(6):1289-94.
  • Gracey M, Bridge E, Martin D, Jones TW, Spargo RM, Shephard M, et al. An Aboriginal-driven program to prevent, control and manage nutrition-related" lifestyle" diseases including diabetes. Asia Pacific Journal of Clinical Nutrition. 2005;15(2):178-88.
  • Gallego PH, Gilbey AJ, Grant MT, Bulsara MK, Byme GC, Jones TW, et al. Early changes in 24-hour ambulatory blood pressure are associated with high normal albumin excretion rate in children with type 1 diabetes mellitus. Journal of pediatric endocrinology & metabolism : JPEM. 2005;18(9):879-85.
  • Windsor L, Morahan G, Huang D, McCann V, Jones TW, James I, et al. Alleles of the IL12B 3′ UTR Associate with Late Onset of Type 1 Diabetes. Human Immunology. 2004;65(12):1432-6.
  • Watts K, Beye P, Siafarikas A, O'Driscoll G, Jones TW, Davis EA, et al. Effects of exercise training on vascular function in obese children. The Journal of pediatrics. 2004;144(5):620-5.
  • Watts K, Beye P, Siafarikas A, Davis EA, Jones TW, O'Driscoll G, et al. Exercise training normalizes vascular dysfunction and improves central adiposity in obese adolescents. Journal of the American College of Cardiology. 2004;43(10):1823-7.
  • Ward BK, Magno AL, Davis EA, Hanyaloglu AC, Stuckey BG, Burrows M, et al. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism. J Clin Endocrinol Metab. 2004;89(8):3721-30.
  • Siafarikas A, Watts K, Beye P, Jones TW, Davis EA, Green DJ. Lack of effect of oral glucose loading on conduit vessel endothelial function in healthy subjects. Clinical science (London, England : 1979). 2004;107(2):191-6.
  • McMahon SK, Haynes A, Ratnam N, Grant MT, Carne CL, Jones TW, et al. Increase in type 2 diabetes in children and adolescents in Western Australia. The Medical journal of Australia. 2004;180(9):459-61.
  • Haynes A, Bower C, Bulsara MK, Jones TW, Davis EA. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985-2002). Diabetologia. 2004;47(5):866-70.
  • Bulsara MK, Holman CD, Davis EA, Jones TW. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies-what method should we use? Diabetic medicine : a journal of the British Diabetic Association. 2004;21(8):914-9.
  • Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes care. 2004;27(10):2293-8.
  • McLennan K, Jeske Y, Cotterill A, Cowley D, Penfold J, Jones TW, et al. Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clinical Endocrinology. 2003;58(6):785-94.
  • Jones TW, Davis EA. Hypoglycaemia (chapter). In: Menon RK, Sperling M, Klewer, editors. Pediatric diabetes: Klewer; 2003. p. 369-88.
  • Jones TW, Davis EA. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatric Diabetes. 2003;4(3):143-50.
  • Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia. Diabetic medicine : a journal of the British Diabetic Association. 2003;20(3):238-41.
  • Roberts L, Jones TW, Fournier PA. Exercise training and glycemic control in adolescents with poorly controlled type 1 diabetes mellitus. Journal of pediatric endocrinology & metabolism : JPEM. 2002;15(5):621-7.
  • Davis EA, Jones TW. Hypoglycaemia in Type 1 Diabetes. Diabetes Management. 2002(December 2002).
  • Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, et al. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2002;22(3):271-9.
  • Frazer FL, Palmer LJ, Clarey A, Thonell S, Byrne GC. Relationship between renal volume and increased albumin excretion rates in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2001;14(7):875-81.
  • Weber IT, Harrison RW, Davis EA, Cuesta Munoz A, Matschinsky FM. Molecular modeling of human glucokinase-implications for the activity of mutants. Molecular pathogenesis of MODYs. Frontiers in Diabetes. 2000;15:109-21.
  • Matschinsky FM, Davis EA, Cuesta Munoz A, Buettger C, Sweet I, Moates M, et al. The glucokinase system and the regulation of blood sugar. Molecular pathogenesis of MODYs. Frontiers in Diabetes. 2000;15:99-108.
  • Mahalingam B, Cuesta-Munoz A, Davis EA, Matschinsky FM, Harrison RW, Weber IT. Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia. Diabetes. 1999;48(9):1698-705.
  • Davis EA, Cuesta-Munoz A, Raoul M, Buettger C, Sweet I, Moates M, et al. Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis. Diabetologia. 1999;42(10):1175-86.
  • Burke CV, Buettger CW, Davis EA, McClane SJ, Matschinsky FM, Raper SE. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). The Biochemical journal. 1999;342 ( Pt 2):345-52.
  • Attia N, Caprio S, Jones TW, Heptulla R, Holcombe J, Silver D, et al. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. The Journal of clinical endocrinology and metabolism. 1999;84(7):2324-8.
  • Matschinsky FM, Davis EA. The distinction between 'glucose setpoint', 'glucose threshold' and 'glucose sensor ' is critical for understanding the role of the pancreatic ß-cell in glucose homeostasis. In: Molinatti GM, Porta M, Belfiore F, Lorenzi M, editors. Molecular and Cell Biology of Type 2 Diabetes and Its Complications. Frontiers in Diabetes. 14. Turin: 5th International Diabetes Conference; 1998. p. 14-29.
  • Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. The New England journal of medicine. 1998;338(23):1657-62.
  • Glaser B, Kesavan P, Heyman M, Davis EA, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. New England Journal of Medicine. 1998;338(4):226-30.
  • Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Impact of improved glycaemic control on rates of hypoglycaemia in insulin dependent diabetes mellitus. Archives of disease in childhood. 1998;78(2):111-5.
  • Davis EA, Jones TW. Hypoglycemia in children with diabetes: incidence, counterregulation and cognitive dysfunction. Journal of pediatric endocrinology & metabolism : JPEM. 1998;11 Suppl 1:177-82.
  • Attia N, Jones TW, Holcombe J, Tamborlane WV. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes care. 1998;21(5):817-21.
  • Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. The Journal of pediatrics. 1997;130(3):366-72.
  • Morris AD, Ueda S, Petrie JR, Connell JM, Elliott HL, Donnelly R. The euglycaemic hyperinsulinaemic clamp: an evaluation of current methodology. Clinical and experimental pharmacology & physiology. 1997;24(7):513-8.
  • Kesavan P, Wang L, Davis EA, Cuesta A, Sweet I, Niswender K, et al. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochemical Journal. 1997;322( Pt 1):57-63.
  • Jones TW, Borg WP, Borg MA, Boulware SD, McCarthy G, Silver D, et al. Resistance to neuroglycopenia: an adaptive response during intensive insulin treatment of diabetes. The Journal of clinical endocrinology and metabolism. 1997;82(6):1713-8.
  • Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes care. 1997;20(1):22-5 
  • Davis EA, Jones TW, Walsh P, Byrne GC. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM. Diabetes care. 1997;20(9):1448-53.
  • Couper JJ, Clarke CF, Byrne GC, Jones TW, Donaghue KC, Nairn J, et al. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association. 1997;14(9):766-71.
  • Porter PA, Byrne G, Stick S, Jones TW. Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus. Archives of disease in childhood. 1996;75(2):120-3.
  • Davis EA, Valentine JP, D'Orsogna L. Aortic aneurysm complicating bacterial endocarditis in childhood. J Paediatr Child Health. 1996;32(1):68-70.
  • Davis EA, Soong SA, Byrne GC, Jones TW. Acute hyperglycaemia impairs cognitive function in children with IDDM. Journal of pediatric endocrinology & metabolism : JPEM. 1996;9(4):455-61.
  • Stubberfield TG, Byrne GC, Jones TW. Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation. Journal of pediatric endocrinology & metabolism : JPEM. 1995;17(2):167-71.
  • Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV. Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children. The Journal of pediatrics. 1995;126(2):171-7.
  • Girardi NL, Shaywitz SE, Shaywitz BA, Marchione K, Fleischman SJ, Jones TW, et al. Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder. Pediatric Research. 1995;38(4):539-42.
  • Couper JJ, Jones TW, Donaghue KC, Clarke CF, Thomsett MJ, Silink M. The Diabetes Control and Complications Trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group. The Medical journal of Australia. 1995;162(7):369-72.
  • Willis FR, Byrne GC, Jones TW. Fludrocortisone induced heart failure in Addison's disease. Journal of Paediatrics and Child Health. 1994;30(3):280-1.
  • Kelly HA, Russell MT, Jones TW, Byrne GC. Dramatic increase in incidence of insulin dependent diabetes mellitus in Western Australia. The Medical journal of Australia. 1994;161(7):426-9.
  • Caprio S, Jones TW, Tamborlane W. Developmental changes in insulin action and secretion in childhood health and disease. Advances in Endocrinology & Metabolism. 1994;5:171-201.
  • Kelly H, Jones TW, Byrne G. Diabetes - National Action Plan (letter). The Medical journal of Australia. 1993;159(11-12):838.
  • Jones TW, Boulware SD, Caprio S, Merkel P, Amiel SA, Pearson HA, et al. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. Pediatric Research. 1993;33(5):497-500.
  • Diamond MP, Jones TW, Caprio S, Hallarman L, Diamond MC, Addabbo M, et al. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism. 1993;42(12):1568-72.
  • Chen QY, Rowley MJ, Byrne GC, Jones TW, Tuomi T, Knowles WJ, et al. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Pediatric Research. 1993;34(6):785-90.
  • Diamond MP, Reece EA, Caprio S, Jones TW, Amiel S, DeGennaro N, et al. Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus. American journal of obstetrics and gynecology. 1992;166(1 Pt 1):70-7 
  • Jones TW, Caprio S, Diamond MP, Hallarman L, Boulware SD, Sherwin RS, et al. Does insulin species modify counterregulatory hormone response to hypoglycemia? Diabetes care. 1991;14(8):728-31.
  • Jones TW, Caprio S, Amiel SA, Sherwin RS, Tamborlane WV. Glycaemic thresholds for counter-regulatory responses. In: Federlin K, Keen H, Meinert H, editors. International Symposium on "Hypoglycaemia and Human Insulin". Stuttgart; New York: G. Thieme; 1991. p. 33-7.
  • Jones TW, Boulware SD, Tamborlane WV. Management of type 1 diabetes in children. In: Lebowitz HF, DeFronzo R, Genuth S, Kreisberg R, Pfeifer M, Tamborlane WV, editors. Therapy of Diabetes Mellitus and Related Disorders: American Diabetes Association; 1991. p. 44-51.
  • Jones TW, Boulware SD, Kraemer DT, Caprio S, Sherwin RS, Tamborlane WV. Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes. 1991;40(3):358-63.
  • Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connolly-Howard M, Tamborlane WV, et al. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. The Journal of clinical endocrinology and metabolism. 1991;72(6):1388-90.
  • Caprio S, Gerety G, Tamborlane WV, Jones T, Diamond M, Jacob R, et al. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. The American journal of physiology. 1991;260(6 Pt 1):E852-8.
  • Boulware SD, Jones TW, Tamborlane WV. Insulin Dependent Diabetes in Children. In: Bardin CW, editor. Current therapy in endocrinology and metabolism. Current therapy series. 4th ed. ed: Mosby Elsevier Health Science; 1991.
  • Zhang J, Logan K, Yu XB, Davis EA, Posner M, Ackerman S. Early events of RNA polymerase II transcription initiation. Life sciences. 1990;46(10):729-35.
  • Jones TW, McCarthy G, Tamborlane WV, Caprio S, Roessler E, Kraemer D, et al. Mild hypoglycemia impairs brainstem and cortical evoked potentials in normal subjects. Diabetes. 1990;39(12):1550-5.
  • Jones TW, Caprio S, Boulware SD, Pearson HA, Merkel P, Sherwin PS, et al. Long-Term Glyburide Therapy Corrects Hyperinsulinemia In Nondiabetic Patients With Thalassemia Major (Tm). Pediatric Research. 1990;27(4):A144-A.
  • Tamborlane WV, Caprio S, Boulware SD, Jones TW, Simonsen D, Amiel S. Changes in Insulin Sensitivity and Counter-regulatory Responses of Puberty. In: Larkins R, Zimmet P, Chisholm DJ, editors. Diabetes 1988: proceedings of the 13th Congress of the International Diabetes Federation, Sydney, 20-25 November 1988. 13 of Congress of the International Diabetes Federation. Amsterdam: Elsevier Science Publishers; 1989. p. 585-8.
  • Logan K, Zhang J, Davis EA, Ackerman S. Drug inhibitors of RNA polymerase II transcription. DNA (Mary Ann Liebert, Inc). 1989;8(8):595-604.
  • Kundzicz H, Davis EA, Ackerman S. RNA polymerase II transcription complexes are destabilized by ATP or GTP. Biochemical and biophysical research communications. 1989;162(3):1133-9.
  • Jones TW, Henderson TR. Urinary calculi in children in Western Australia: 1972-86. Australian paediatric journal. 1989;25(2):93-5.